investor biotimeinc.com

Overview Investors Media BioTime, Inc.

BioTime is a clinical-stage biotechnology company committed. To delivering novel products based on regenerative medicine. To patients with serious diseases and degenerative conditions. For which there presently are no cures. 160;-0.02. Rodman and Renshaw Annual Global Investment Conference. September 08, 2015throughSeptember 10, 2015. BioTime, Inc. Second Quarter 2015 Financial Results. August 07, 2015throughAugust 10, 2015. BioTime, Inc. Annual Meeting of Shareholders. July 10, 2015. July 29, 2015.
traffic

OVERVIEW

This web page investor.biotimeinc.com currently has a traffic ranking of zero (the lower the superior). We have scanned one page inside the domain investor.biotimeinc.com and found seven websites referring to investor.biotimeinc.com. We were able to observe five social web platforms enjoyed by this website.
Pages Crawled
1
Links to this site
7
Social Links
5

INVESTOR.BIOTIMEINC.COM RANKINGS

This web page investor.biotimeinc.com has seen varying levels of traffic until the end of the year.
Traffic for investor.biotimeinc.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.biotimeinc.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.biotimeinc.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES INVESTOR.BIOTIMEINC.COM LOOK LIKE?

Desktop Screenshot of investor.biotimeinc.com Mobile Screenshot of investor.biotimeinc.com Tablet Screenshot of investor.biotimeinc.com

INVESTOR.BIOTIMEINC.COM HOST

Our parsers discovered that the main page on investor.biotimeinc.com took zero milliseconds to come up. Our parsers could not detect a SSL certificate, so we consider investor.biotimeinc.com not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
184.51.0.218

BROWSER ICON

PAGE TITLE

Overview Investors Media BioTime, Inc.

DESCRIPTION

BioTime is a clinical-stage biotechnology company committed. To delivering novel products based on regenerative medicine. To patients with serious diseases and degenerative conditions. For which there presently are no cures. 160;-0.02. Rodman and Renshaw Annual Global Investment Conference. September 08, 2015throughSeptember 10, 2015. BioTime, Inc. Second Quarter 2015 Financial Results. August 07, 2015throughAugust 10, 2015. BioTime, Inc. Annual Meeting of Shareholders. July 10, 2015. July 29, 2015.

CONTENT

This web page investor.biotimeinc.com states the following, "BioTime is a clinical-stage biotechnology company committed." We saw that the website said " To delivering novel products based on regenerative medicine." It also said " To patients with serious diseases and degenerative conditions. For which there presently are no cures. Rodman and Renshaw Annual Global Investment Conference. September 08, 2015throughSeptember 10, 2015. Second Quarter 2015 Financial Results. August 07, 2015throughAugust 10, 2015." The header had Regenerative medicine as the highest ranking optimized keyword. It is followed by wound healing, embryonic stem cells, and embryonic stem cells which isn't as ranked as highly as Regenerative medicine. The next words investor.biotimeinc.com used was hyaluronate. Biotime was included but could not be viewed by search engines.

SEEK SIMILAR DOMAINS

Bizeso Investor

Content on this page requires a newer version of Adobe Flash Player. It totally depends upon the project viability. Monday, January 25, 2010. Congo, The Democratic Republic Of The. Heard and Mc Donald Islands. Saint Vincent and the Grenadines.

Investor Relations

Blueknight Energy Partners, L. is a publicly traded master limited partnership formed in July 2007. It is our vision to use our strategically located assets to be a leading provider of midstream services in the energy industry. Crude Oil Terminalling and Storage. Crude Oil Gathering and Transportation Services. Asphalt Terminalling, Storage and Processing Services.

Blount International, Inc.Investor Relations

Farm, Ranch and Agriculture. Blount common stock is traded on the New York Stock Exchange under the ticker symbol BLT. is incorporated under the laws of the state of Delaware. Shareholders with questions about More. Data Provided by Thomson Reuters. Blount Announces Preliminary Second Quarter 2015 Results. Blount International Announces New Board Member. 2014 Blount International, Inc.

Blucora Home Blucora

We turn taxes into opportunity. For many, taxes represent anxiety and lack of control. TaxAct is the simple and affordable online tax filing system that makes it easy for people to accurately file their own taxes and discover opportunities for tax savings.